QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)
QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)
QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)
QQQ   418.91 (-1.06%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   150.64 (-2.86%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.68 (-1.48%)
CGC   7.75 (-1.02%)
DIS   111.76 (-0.60%)
AMC   3.14 (+7.53%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.40 (+1.59%)

The Cheesecake Factory Continues to Look Appetizing (NASDAQ: CAKE)

The Cheesecake Factory Continues to Look Appetizing (NASDAQ: CAKE)The recent update from Moderna (NASDAQ: MRNA) on their COVID vaccine has added fuel to the recovery rally and in particular, non-tech names that didn’t sparkle too bright this summer stand to do well. That means the likes of cruise ships, airlines, and hotels all stand poised to have a solid end to a year that for many looked like the last one they might be in business for. The same is true for restaurant stocks, with shares of the California based Cheesecake Factory (NASDAQ: CAKE) already seeing a strong bid.

When it rains it pours and so it’s been for their shares who have picked up several fresh upgrades in recent days. A 160% move from Q1’s low into November certainly had the stock on Wall Street’s radar, all the more so because it’s a classic restaurant name and so on the front line of any COVID slowdowns in the economy that filter through to equities. But with the stock now within a few percent of hitting pre-COVID levels, more and more sell-side names are rowing in behind it.

For investors still on the sidelines, there’s a compelling argument to consider the long side as we head into the final six weeks of the year.

Recovery Rally Potential

Even before Moderna’s news last week, the likes of Gordon Haskett were upgrading Cheesecake shares in light of their ongoing recovery driven potential. Their Q3 earnings at the end of October hadn’t been anything to write home about but had removed a decent amount of uncertainty that had been hanging over them.


As well as moving them to a Buy rating from Accumulate, Gordon Haskett noted how "the company has unlocked sustainable same store sales drivers well into 2021 and CAKE will emerge from the COVID landscape with a higher margin revenue mix and leaner cost structure. CAKE is positioned to see a multi-quarter run of upward EBITDA and EPS revisions as the Street will likely continue to view CAKE as a show-me story given the concept’s late to develop same-store sales recovery progress."

A week later Deutsche Bank upgraded shares from Hold to Buy, feeling that they were still undervalued even after a solid run over the previous few weeks. In a note to clients they said "outside of near-term weather and COVID risks (which we acknowledge), and for CAKE specifically, we sense a reluctance to fully embrace a bull case here just given legacy issues and biases as it pertains to CAKE’s mall exposure. And while we definitely can understand this, as well as the viewpoint that there are other preferable names in Casual Dining, we are just articulating our opinion that on a stand-alone basis we think CAKE is undervalued."

Getting Involved

This was solid new sentiment for the bulls to be feeding from and then Moderna hit the headlines. That put hospitality stocks firmly back in favor and seems to have been the signal that many firms were waiting for. Since then both Argus and CFRA have moved shares from a Hold rating to Buy, both noting the huge potential for a fresh recovery rally as economies start planning to fully reopen with confidence. All the signs point to 2021 being the year that beaten down COVID stocks bounce back harder than ever as consumers play catch up on all the missed trips, vacations, and meals out with friends.

More recently, Cheesecake’s 50 day moving average crossed over its 200-day moving average back in October, a super bullish technical signal called the Golden Cross. Since then shares have traded above the 50-day line which is acting as solid support and provides a good entry point for anyone looking to dip the toe in now and to start positioning for next year.

The Cheesecake Factory Continues to Look Appetizing (NASDAQ: CAKE)

Should you invest $1,000 in Cheesecake Factory right now?

Before you consider Cheesecake Factory, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cheesecake Factory wasn't on the list.

While Cheesecake Factory currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Cheesecake Factory (CAKE)
3.4278 of 5 stars
$33.89+0.2%3.19%16.45Hold$35.64
Moderna (MRNA)
3.9911 of 5 stars
$102.74+0.7%N/A-8.28Hold$126.49
Compare These Stocks  Add These Stocks to My Watchlist 

Sam Quirke

About Sam Quirke

  • s.quirke.us@gmail.com

Contributing Author

Technical Analysis

Experience

Sam Quirke has been a contributing writer for MarketBeat since 2019.

Areas of Expertise

Technical and fundamental analysis, tech stocks, large caps, timing entries and exits

Education

Trinity College, Dublin, Ireland

Past Experience

Professional futures trader, start-up fund manager


Featured Articles and Offers

Search Headlines: